Intuitive Surgical (STU:IUI1) EBIT: €2,770 Mil (TTM As of Mar. 2026)


STU:IUI1 Intuitive Surgical Inc STU:IUI1
91 GF Score
Price €351.25
GF Value €528.17
Valuation Significantly Undervalued
! 1 Warning Sign
View Full Analysis

What is Intuitive Surgical EBIT?

Intuitive Surgical STU:IUI1 -0.61% 91 EBIT is €2,770 Mil as of Mar. 2026. GuruFocus rates STU:IUI1 with a GF Score™ of 91/100 and a GF Value™ of €528.17 (Significantly Undervalued). The stock has 1 warning sign investors should review.

Intuitive Surgical's earnings before interest and taxes (EBIT) for the three months ended in Mar. 2026 was €740 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2026 was €2,770 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Intuitive Surgical's annualized ROC % for the quarter that ended in Mar. 2026 was 21.38%. Intuitive Surgical's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 47.19%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Intuitive Surgical's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 2.29%.


Intuitive Surgical  (STU:IUI1) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Intuitive Surgical's annualized ROC % for the quarter that ended in Mar. 2026 is calculated as:

ROC % (Q: Mar. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2025 ) + Invested Capital (Q: Mar. 2026 ))/ count )
=2959.336 * ( 1 - 12.17% )/( (11676.486 + 12640.159)/ 2 )
=2599.1848088/12158.3225
=21.38 %

where

Invested Capital(Q: Dec. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=17471.73 - 726.839 - ( 5068.405 - max(0, 1713.295 - 8351.693+5068.405))
=11676.486

Invested Capital(Q: Mar. 2026 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=17396.015 - 848.392 - ( 3907.464 - max(0, 1653.015 - 7620.217+3907.464))
=12640.159

Note: The Operating Income data used here is four times the quarterly (Mar. 2026) data.

2. Joel Greenblatt's definition of Return on Capital:

Intuitive Surgical's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 is calculated as:

ROC (Joel Greenblatt) %(Q: Mar. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2025  Q: Mar. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=2959.336/( ( (4562.41 + max(1483.824, 0)) + (4712.433 + max(1782.938, 0)) )/ 2 )
=2959.336/( ( 6046.234 + 6495.371 )/ 2 )
=2959.336/6270.8025
=47.19 %

where Working Capital is:

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(1304.314 + 1571.36 + 321.445) - (726.839 + 432.722 + 553.734)
=1483.824

Working Capital(Q: Mar. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(1203.301 + 1682.511 + 550.141) - (848.392 + 483.967 + 320.656)
=1782.938

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Intuitive Surgical's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Mar. 2026 )
=2769.738/120806.086
=2.29 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Intuitive Surgical EBIT Related Terms


Intuitive Surgical EBIT Historical Data

* Premium members only.

The historical data trend for Intuitive Surgical's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Intuitive Surgical EBIT Chart

Intuitive Surgical Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,611.59 1,488.78 1,620.16 2,243.20 2,515.46

Intuitive Surgical Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 534.74 644.53 647.26 738.11 739.83

STU:IUI1 vs BDX, MDLN, RMD: EBIT Comparison

For the Medical Instruments & Supplies subindustry, Intuitive Surgical's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Intuitive Surgical EV-to-EBIT vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Intuitive Surgical's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Intuitive Surgical's EV-to-EBIT falls into.


STU:IUI1
91GF Score
Intuitive Surgical Inc STU:IUI1
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Intuitive Surgical EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €2,770 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of €2,770 Mil mean?
Intuitive Surgical (STU:IUI1) has a EBIT of €2,770 Mil as of Mar. 2026. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Intuitive Surgical.
Is Intuitive Surgical's EBIT too high?
Intuitive Surgical's current EBIT is €2,770 Mil. Overall, Intuitive Surgical has a GF Score™ of 91/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Intuitive Surgical's EBIT compare to BDX and MDLN?
Intuitive Surgical's EBIT of €2,770 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Medical Devices & Instruments company?
A good EBIT depends on the Medical Devices & Instruments industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Intuitive Surgical. Intuitive Surgical's current EBIT is €2,770 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Intuitive Surgical stock overvalued right now?
Based on GuruFocus' analysis, Intuitive Surgical (STU:IUI1) is currently considered Significantly Undervalued. The stock's GF Value™ is €528.17, compared to a current price of €351.25 — trading 33.5% below its estimated fair value. The current EBIT is €2,770 Mil. Intuitive Surgical's overall GF Score™ is 91/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Intuitive Surgical (STU:IUI1), the current EBIT is €2,770 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Intuitive Surgical (STU:IUI1) Overvalued in 2026?

Based on GuruFocus' analysis, Intuitive Surgical stock appears to be undervalued. The current stock price of €351.25 is trading 33.5% below its estimated GF Value™ of €528.17. GuruFocus considers Intuitive Surgical to be Significantly Undervalued.

Key valuation signals for STU:IUI1:

  • EBIT: €2,770 Mil
  • GF Value™: €528.17 vs. price of €351.25 (33.5% below fair value)
  • GF Score™: 91/100 with 1 warning sign

No single metric tells the full story. See the STU:IUI1 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Intuitive Surgical Business Description

Address 1020 Kifer Road, Sunnyvale, CA, USA, 94086
Intuitive develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed more than 10,000 da Vinci systems in hospitals worldwide, with more than 6,000 installations in the US and a growing number in emerging markets.
91GF Score

Get the complete analysis for STU:IUI1

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€351.25
Price
€528.17
GF Value